Autor: |
Gwen Schroyen, Charlotte Sleurs, Tine Ottenbourgs, Nicolas Leenaerts, Ines Nevelsteen, Michelle Melis, Ann Smeets, Sabine Deprez, Stefan Sunaert |
Jazyk: |
angličtina |
Rok vydání: |
2023 |
Předmět: |
|
Zdroj: |
Translational Oncology, Vol 37, Iss , Pp 101769- (2023) |
Druh dokumentu: |
article |
ISSN: |
1936-5233 |
DOI: |
10.1016/j.tranon.2023.101769 |
Popis: |
Background: Previous case studies have provided evidence for chemotherapy-induced leukoencephalopathy in patients with breast cancer. However, prospective research is lacking. Hence, we investigated leukoencephalopathy before and after chemotherapy and its association with a serum neuroaxonal damage marker. Methods: This prospective cohort study included 40 patients receiving chemotherapy for breast cancer, and two age- and education-matched control groups, recruited between 2018 and 2021 (31–64 years of age). The latter control groups consisted of 39 chemotherapy-naïve patients and 40 healthy women. Fluid-attenuated inversion-recovery magnetic resonance imaging was used for lesion volumetry (total, juxtacortical, periventricular, infratentorial, and deep white matter) and blood serum to measure neurofilament light chain (NfL) levels. Acquisition took place pre-chemotherapy and three months and one-year post-chemotherapy, or at corresponding intervals. Within/between group differences were compared using robust mixed-effects modeling, and associations between total lesion volume and serum-NfL with linear regression. Results: Stronger increases in deep white matter lesion volumes were observed shortly post-chemotherapy, compared with healthy women (ßstandardized=0.09, pFDR0.70, p |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|